Amgen Inc.
Location
California
Founded
1980-02-13
Website
Risk Signals
15490 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Biological Products, Except Diagnostic Substances), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Amgen Inc.
Live alerts from global media, monitored by Business Radar
2025-08-28 (oncodaily.com)
Redefining Precision Medicine Beyond Oncology with AI and Real-World Data - Amgen -
Redefining Precision Medicine Beyond Oncology with AI and Real-World Data - Amgen / AI, Amgen, cancer, Michael Montalto, OncoDaily, Oncology, Talking
Read more
2025-08-28 (oncodaily.com)
What if You Could Lock Disease Biology Into Place? - Amgen -
What if You Could Lock Disease Biology Into Place? - Amgen / Amgen, cancer, clinical trials, OncoDaily, Oncology
Read more
2025-08-28 (stocktradersdaily.com)
Responsive Playbooks and the AMGN Inflection -
Price-action only: Amgen Inc. (AMGN) movements set the tone for institutional models. Responsive Playbooks and the AMGN Inflection
Read more
2025-08-28 (mmm-online.com)
Rx Rundown: AbbVie, Novartis, MannKind and more
Check out this week's medical marketing news, dealmaking and industry chatter.
Read more
2025-08-28 (etf.capital)
Amgen Unveils Gene Therapy Platform for Rare Diseases
Amgen presents a new genetic therapy platform that is only devoted to rare, genetically related diseases. For biotech investors, a potential trendsetter in a market in which <5% of the 100,000 known rare diseases are dealt with so far.
Read more
2025-08-28 (prnewswire.co.uk)
Veeva Announces Collaboration with Global Biotech to Further Accelerate Clinical Trial Innovation
/PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced a collaboration with Amgen to advance clinical trial innovation. As a global leader in...
Read more
2025-08-28 (endpoints.news)
Protein degrader startup Plexium raises $60M, loses Amgen pact
Plexium has corralled another $60 million from investors. The biotech's $500 million pact with Amgen, outlined in 2022, has also come to an end.
Read more
2025-08-27 (citeline.com)
Colorado Board Adopts Medicare Maximum Fair Price For Enbrel, Assumes Amgen 'Amenable'
The state's prescription drug affordability board could be the first to recommend an upper payment limit for a prescription drug.
Read more
2025-08-27 (newstrail.com)
Ependymoma Market Trends: Emerging Innovations and Dynamics -
The latest research report published by Prophecy Market Insights with title Ependymoma Market offers a thorough market analysis. It presents key market data
Read more
2025-08-27 (nbc.com)
Watch Live: Amgen Irish Open - Rd 3 - NBC.com
Watch DP World Tour on NBC.com.
Read more
2025-08-27 (newstrail.com)
Migraine Drugs Market Is Booming Worldwide | Pharmaceuticals, Pfizer , Merck , Amgen -
HTF MI recently introduced Global Migraine Drugs Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates
Read more
2025-08-27 (teleborsa.it)
The American market with the S&P 500 that closes on new records are positive | .it
The US price list shows a gain in closing, with the Dow Jones that scored +0.32%.
Read more